Freemelt receives additional eMELT machine order from Jiuli for Q3 2026 delivery

Freemelt has received a new order for its industrial eMELT electron-beam powder bed fusion (E-PBF) machine from its strategic partner Jiuli, with delivery scheduled for the third quarter of 2026. The order value aligns with previously communicated pricing levels under the collaboration agreement signed in 2025. The machine targets energy and MedTech applications in the local Chinese market, leveraging Jiuli’s local presence, technical expertise, and established business relationships. CEO Daniel Gidlund stated the order validates the technology's value and helps position Freemelt in what he called one of the most expansive and competitive metal AM markets globally.

This repeat order signals continued commercial traction for Freemelt’s E-PBF technology, which competes in the broader electron-beam melting space against established players like GE Additive (Arcam EBM) and newer entrants such as JEOL and Wayland Additive. The Chinese market for metal AM is the fastest-growing globally, driven by government industrial policy and aggressive domestic OEM scale-up. Freemelt’s approach-partnering with a local industrial conglomerate rather than going direct-mirrors the localization pattern seen across the AM value chain, where Western hardware vendors seek Chinese distribution partners to navigate regulatory requirements, build service infrastructure, and access end-user qualification networks. The Jiuli collaboration effectively gives Freemelt a route to market that bypasses the long lead times of building a direct sales and service organization in China from scratch.

For Freemelt, the practical challenge is converting these machine orders into recurring revenue from materials, maintenance, and service-currently forecast at 25% of total revenue by 2030. The company targets SEK 1 billion in revenue by that year, a goal that requires sustained order flow across its three printer models (Freemelt ONE for research, eMELT for industrial production). This Jiuli order is a positive but incremental step; the defining test will be whether the installed base grows fast enough to support the service revenue targets and whether Chinese end users qualify the E-PBF process for serial production in energy and medical applications.